Prof. Dr. med. Sigmund Silber Cardiology Practice and Hospital

Slides:



Advertisements
Similar presentations
Optimal revascularization strategy in patients with three-vessel disease and/or left main disease The 2-year Outcomes of the SYNTAX Trial A. Pieter Kappetein,
Advertisements

Allen Jeremias MD MSc, Sanjay Kaul MD, Luis Gruberg MD, Todd K. Rosengart MD, David L. Brown MD Divisions of Cardiovascular Medicine and Cardiothoracic.
Lésion du tronc commun : reste-t-il une place pour la chirurgie ? La vision de l’angioplasticien Y. Louvard, ICPS, Massy.
Is this the “spioenkop” for CABG?
CABG VS Multi Vessel PCI Hasanat Sharif MD FRCS Chief of Cardiorthoracic Surgery Aga Khan University Hospital.
Cardiology Morning Report: Revascularization in Stable Ischemic Heart Disease Bobby Mathew, MD LSU Internal Medicine, HO-II.
British Cardiac Intervention Society Risk Assessment In Acute Coronary Syndromes Dr David Newby BHF Senior Lecturer in Cardiology Associate Director of.
ARTS I & II Keith D Dawkins Southampton University Hospital.
COURAGE: Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation Purpose To compare the efficacy of optimal medical therapy (OMT)
New ESC/EACTS guidelines on myocardial revascularisation Indications for coronary artery bypass grafting (CABG) vs. percutaneous coronary intervention.
Amr Hassan Mostafa, MD, FSCAI A. Professor of Cardiology Cairo University Cairo, Egypt Egypt Combat MI, March 24-25, Cairo Sheraton.
The Impact of Practice Guideline Changes on Revascularisation Strategies in Patients with Multivessel and Left Main Disease William WIJNS Aalst, Belgium.
Arterial Revascularization Therapies Part II: a non- randomized comparison of contemporary PCI and coronary artery bypass grafting (CABG) in patients with.
The Synergy between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery: The SYNTAX Study One Year Results of the PCI and CABG Registries.
David Hildick-Smith Sussex Cardiac Centre. Background to ARTS Previous POBA studies Meta-analysis 3300 patients 1660 CABG, 1710 PTCA Deaths 79 PCI vs.
PCI v CABG Dr Rod Stables The Cardiothoracic Centre Liverpool UK.
PRACTICAL RECOMMENDATIONS ON ANTI- THROMBOTIC TREATMENT IN PATIENTS TREATED WITH DRUG-ELUTING STENTS Giuseppe Biondi-Zoccai Ospedale S. Giovanni Battista.
Bangalore S, et al. β-Blocker use and clinical outcomes in stable outpatients with and without coronary artery disease. JAMA. 2012;308(13): ?
Lianglong Chen MD PhD FACC
Samuel Thomas Rayburn, III MD Cardiovascular Surgeon Jack Stephens Heart Institute April 25, 2015.
Ten Year Outcome of Coronary Artery Bypass Graft Surgery Versus Medical Therapy in Patients with Ischemic Cardiomyopathy Results of the Surgical Treatment.
Date of download: 6/24/2016 Copyright © The American College of Cardiology. All rights reserved. From: The Year in Cardiovascular Surgery J Am Coll Cardiol.
Date of download: 7/8/2016 Copyright © The American College of Cardiology. All rights reserved. From: Fractional Flow Reserve Versus Angiography for Guiding.
Survival Benefits in Higher Risk Patients Coronary Revascularization has Revolutionized the Therapy of Ischemic Heart Disease Acute coronary syndromes.
Durable Polymer DES: 5 Year Outcomes RESOLUTE Update Sigmund Silber, MD FESC, FACC, FAHA Heart Center at the Isar Munich, Germany On Behalf of the RESOLUTE.
Prof. Dr. Sigmund Silber, FESC, FACC On behalf of the RESOLUTE
S Ten Tse and Sensibility!
Ajay J. Kirtane, MD I have no real or apparent conflicts of interest to report.
September 18th 2012 Case #3: KA, 70 yr M
Final Five-Year Follow-up of the SYNTAX Trial: Optimal Revascularization Strategy in Patients With Three-Vessel Disease and/or Left Main Disease Patrick.
Figure 1 A flow chart describing the systematic process followed for article selection.  From: A systematic review of cost-effectiveness of percutaneous.
CABG in diabetics: surgical aspects
Figure 3 One-year adverse events (death, post-discharge myocardial infarction, revascularization) after PCI according to patients who (A) would not have.
The European Society of Cardiology Presented by Dr. Bo Lagerqvist
David R. Holmes, MD Mayo Clinic Rochester, MN
SYNTAX at 2 Years: This Interventionalist’s Perspective
Debate: What Does the Future Hold for the Treatment of Unprotected Left Main Disease? More PCI No More Routine Surgery Ron Waksman, MD, FACC Washington.
A Pooled Analysis From SYNTAX and BEST Randomized trials
On behalf of J. Belardi, M. Leon, L. Mauri,
Novel Trial Design Focus - Left Main and “All Comers” DES Studies
The Guidelines Should Be Change!
EXCEL Evaluation of Xience Prime versus Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization Gregg W. Stone MD Columbia University.
Percutaneous coronary invervention versus coronary artery bypass grafting: A meta- analysis  Yolba Smit, MD, MSc, Joan Vlayen, MD, Hetty Koppenaal, MD,
Unprotected Left Main Intervention How To Perform A Safe PCI
Glenn N. Levine et al. JACC 2016;68:
American College of Cardiology Presented by Dr. Stephan Windecker
2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease  Glenn N. Levine, MD, FACC, FAHA,
Invasive versus conservative treatment in unstable coronary syndromes
Peter K. Smith, MD  The Journal of Thoracic and Cardiovascular Surgery 
Peter K. Smith, MD  The Annals of Thoracic Surgery 
J. Trevor Posenau, MD, Daniel M. Wojdyla, MS, Linda K
The Synergy between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery: The SYNTAX Study One Year Results of the PCI and CABG Registries.
Effect of PCI on 1-year risk of all-cause mortality and major cardiovascular outcomes. CABG, coronary artery bypass grafting; CI, confidence interval (bars);
Incidence and management of restenosis after treatment of unprotected left main disease with drug-eluting stents: 70 restenotic cases from a cohort of.
Three-Year Outcomes of Multivessel Revascularization in Very Elderly Acute Coronary Syndrome Patients  Brett C. Sheridan, MD, Sally C. Stearns, PhD, Joseph.
Global Registry of Acute Coronary Events: GRACE
Early and long-term outcomes of coronary artery bypass grafting in patients with acute coronary syndrome versus stable angina pectoris  Toshihiro Fukui,
Hisato Takagi, MD, PhD, Hideaki Manabe, MD, Takuya Umemoto, MD, PhD 
The Synergy between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery: The SYNTAX Study One Year Results of the PCI and CABG Registries.
DEScover: One-Year Clinical Results
Stent Versus Off-Pump Coronary Bypass Grafting in the Second-Generation Drug- Eluting Stent Era  Gijong Yi, MD, PhD, Hyun-Chel Joo, MD, Young-Nam Youn,
Glenn N. Levine et al. JACC 2011;58:e44-e122
Figures showing the effects of a potential 30% relative reduction in events with next-generation drug-eluting stents in the percutaneous coronary intervention.
Lee A. Fleisher et al. JACC 2014;64:e77-e137
Effect of PCI on 3 to 5-year risk of all-cause mortality and major cardiovascular outcomes. CABG, coronary artery bypass grafting; CI, confidence interval.
Improved Long-Term Survival for Diabetic Patients With Surgical Versus Interventional Revascularization  Paul Kurlansky, MD, Morley Herbert, PhD, Syma.
Use of evidence-based cardiac medications before, during and after hospitalisation for the index event in (A) overall ACS population and (B) patients with.
FFR guided deferral of PCI in patients with ACS and stable coronary artery disease (SCAD). FFR guided deferral of PCI in patients with ACS and stable coronary.
Proposed future revascularisation strategy in patients with ESRD based on our current results and previous guideline recommendations. Proposed future revascularisation.
Presentation transcript:

Prof. Dr. med. Sigmund Silber Cardiology Practice and Hospital FACC, FESC Cardiology Practice and Hospital Munich, Germany Outpatient Practice Heart Center at the Isar

New Guidelines for Myocardial Revascularization ESC Stockholm 29th of August 2010

The 2010 ESC Guidelines replaced the previously published ESC Guidelines The following ESC Guidelines are very relevant for Myocardial Revascularisation and served as background and foundation for our Task Force: Silber S, Albertsson P, Aviles FF, et al. Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology. Eur Heart J 2005;26:804-847. Fox K, Garcia MA, Ardissino D, et al. Guidelines on the management of stable angina pectoris: executive summary: The Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology. Eur Heart J 2006;27:1341-1381. Bassand JP, Hamm CW, Ardissino D, et al. Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes. Eur Heart J 2007;28:1598-1660. Van De Werf F, Bax J, Betriu A, et al. Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J 2008;29:2909-2945.

only 46 pages !

EHJ, 31: 2501-2555, (2010)

Clinical cardiologist (non interventional) Interventional cardiologist NEW: The Heart Team Clinical cardiologist (non interventional) The patient with CAD Interventional cardiologist Cardiac surgeon Task Force composition = 8 clinical cardiologists (non interventional) + 9 interventional cardiologists + 8 cardiac surgeons

Do we need the Heart Team for Patients with ACS ? EHJ, 31: 2501-2555, (2010)

The Heart Team for Patients with stable CAD: ˮOculostenotic  Reflexˮ ist o.k. if… Ad hoc PCI is convenient for the patient, associated with fewer access site complications, and often cost-effective. Ad hoc PCI is reasonable for many patients, but not desirable for all, and should not be automatically applied as a default approach.

The Heart Team for Patients with stable CAD: Avoid the ˮOculostenotic  Reflexˮ if… Hospital teams without a cardiac surgical unit or with interventional cardiologists working in an ambulatory setting should refer to standard evidence-based protocols designed in collaboration with an expert interventional cardiologist and a cardiac surgeon, or seek their opinion for complex cases.

Anatomical representation Stenting Aorto-Coronary Bypass Wijns W & Kolh Ph. Eur Heart J. 2009;30(18):2182-5.

Strength of Recommendation:

Strength of Recommendation:

Bypass Surgery (CABG) versus PCI (with predominantly DES) in Patients with stable CAD In the most severe patterns of CAD, CABG appears to offer a survival advantage as well as a marked reduction in the need for repeat revascularisation.

SYNTAX Score is only anatomy, it does not reflect the clinical status Limitation:

SYNTAX-Score > 33: prefer bypass surgery !

EHJ, 31: 2501-2555, (2010) Do the ESC guidelines from 2010 have to be updated after the presentation of SYNTAX 4-years results at the TCT ?

DES in complex multivessel disease: The Syntax Trial at 4 years: Overall results and breakdown of the 3VD cohort Patrick W. Serruys, MD PhD Erasmus Medical Center, Rotterdam, The Netherlands On behalf of the SYNTAX investigators The Moscone Centre 135 9:58-10:10, 7 Nov, 2011 Conflicts of Interest: None 20

All-Cause Death to 4 Years TAXUS (N=903) CABG (N=897) Before 1 year* 3.5% vs 4.4% P=0.37 1-2 years* 1.5% vs 1.9% P=0.53 2-3 years* 1.9% vs 2.6% P=0.32 3-4 years* 2.2% vs 3.2% P=0.22 25 50 P=0.048 Cumulative Event Rate (%) 1 yr data From SYNTAX_CSR_randomized_Unblinded_2008Oct10.doc exhibit 1 2-Year_Randomized_20090917.doc Exhibit 2 (binary interval rate) SYNTAX 3-Year Report_Randomized_12JUL10.doc Exhibit 2 (binary interval rate) SYNTAX 4-Year Report_Randomized_15JUN11.doc exhibits 1 (KM rate on right sidea) and exhibit 2 (binary interval rate in white box) 11.7% 8.8% 12 48 24 36 Months Since Allocation Cumulative KM Event Rate ± 1.5 SE; log-rank P value;*Binary rates ITT population 21

Repeat Revascularization to 4 Years TAXUS (N=903) CABG (N=897) Before 1 year* 5.9% vs 13.5% P<0.001 1-2 years* 3.7% vs 5.6% P=0.06 2-3 years* 2.5% vs 3.4% P=0.33 3-4 years* 1.6% vs 4.2% P=0.002 25 50 P<0.001 Cumulative Event Rate (%) 23.0% 1 yr data From SYNTAX_CSR_randomized_Unblinded_2008Oct10.doc exhibit 1 2-Year_Randomized_20090917.doc Exhibit 2 (binary interval rate) SYNTAX 3-Year Report_Randomized_12JUL10.doc Exhibit 2 (binary interval rate) SYNTAX 4-Year Report_Randomized_15JUN11.doc exhibits 1 (KM rate on right sidea) and exhibit 2 (binary interval rate in white box) 11.9% 12 48 24 36 Months Since Allocation Cumulative KM Event Rate ± 1.5 SE; log-rank P value;*Binary rates ITT population 22

MACCE to 4 Years by SYNTAX Score Tercile High Scores (33) TAXUS (N=290) CABG (N=315) CABG PCI P value Death 8.4% 16.1% 0.004 CVA 3.7% 3.5% 0.80 MI 3.9% 9.3% 0.01 Death, CVA or MI 14.6% 22.7% Revasc. 11.4% 28.8% <0.001 Overall < Months Since Allocation Cumulative Event Rate (%) 12 24 50 25 48 36 P<0.001 40.1% < 23.6% SYNTAX 4-Year Report_Randomized_15JUN11.doc exhibit 56 < < Cumulative KM Event Rate ± 1.5 SE; log-rank P value Site-reported Data; ITT population

MACCE to 4 Years by SYNTAX Score Tercile Intermediate Scores (23-32) TAXUS (N=207) CABG (N=208) CABG PCI P value Death 12.4% 18.6% 0.048 CVA 3.6% 2.5% 0.53 MI 3.1% 10.5% 0.004 Death, CVA or MI 0.09 Revasc. 8.3% 21.0% 0.0005 3-vessel Disease < Months Since Allocation Cumulative Event Rate (%) 12 24 50 25 48 36 > 33.3% P=0.0006 < 4-Year_Randomized_SX23-32(Core)-3VD(Site)_18JUL11.doc exhibit 1 < 17.9% < Cumulative KM Event Rate ± 1.5 SE; log-rank P value Site-reported Data; ITT population

Bypass Surgery (CABG) versus PCI (with predominantly DES) in Patients with stable CAD In the most severe patterns of CAD, CABG appears to offer a survival advantage as well as a marked reduction in the need for repeat revascularisation.

MACCE to 4 Years by SYNTAX Score Tercile Low to Intermediate Scores (0-32) TAXUS (N=221) CABG (N=196) CABG PCI P value Death 11.8% 7.5% 0.12 CVA 3.9% 1.4% 0.11 MI 3.8% 5.1% 0.55 Death, CVA or MI 17.1% 13.5% 0.25 Revasc. 16.9% 19.1% 0.57 Left Main > 40 29.0% > 30 P=0.65 < Cumulative Event Rate (%) Cumulative Event Rate (%) 20 27.6% 10 > < 12 24 36 48 Months Since Allocation Months Since Allocation Cumulative KM Event Rate ± 1.5 SE; log-rank P value Site-reported Data; ITT population

Bypass Surgery (CABG) versus PCI (with predominantly DES) in Patients with stable CAD In the most severe patterns of CAD, CABG appears to offer a survival advantage as well as a marked reduction in the need for repeat revascularisation.

EHJ, 31: 2501-2555, (2010) Do the ESC guidelines from 2010 have to be updated after the presentation of the SYNTAX 4-years results at the TCT ? No ! These data even confirm the ESC recommendations